Tranylcypromine Sulfate

硫酸反苯环丙胺

Report date: 2022/08/16 14:33:04
NME

Base Information

Drug NameTranylcypromine Sulfate
Drug Alias Nametranylcypromine反苯环丙胺半硫酸盐tranilcipromina反苯环丙胺tranylcyprominum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitors
TargetsMonoamine oxidase
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/02/21
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesConcordia
China Registration ClassN/A

Develop Information

Active CompaniesAdvanz Pharma Corp
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN06AF04
Related LinksWikipediaDrugBankKEGG